background
Publication
Evaluation of the Nanosphere Verigene BC-GN Assay for Direct Identification of Gram-Negative Bacilli and Antibiotic Resistance Markers from Positive Blood Cultures and Potential Impact for More-Rapid Antibiotic Interventions
Performance Evaluation of the Verigene® (Nanosphere) and the FilmArray® (BioFire®) Molecular Assays for Identification of Causative Organisms in Bacterial Bloodstream Infections
Real-World Performance of a Microarray-Based Rapid Diagnostic for Gram-Positive Bloodstream Infections and Potential Utility for Antimicrobial Stewardship
Rapid Testing Using the Verigene Gram-Negative Blood Culture Nucleic Acid Test in Combination with Antimicrobial Stewardship Intervention Against Gram-Negative Bacteremia
Impact of a Rapid Microarray Assay for Identification of Positive Blood Cultures on Treatment Optimization for Patients with Streptococcal and Enterococcal Bacteremia
Rapid Testing Using Verigene® Microarray in Combination with Antimicrobial Stewardship Intervention in Gram-Negative Bacteremia
Outcomes of Rapid Identification for Gram Positive Bacteremia in Combination with Antibiotic Stewardship at a Community Based Hospital System
Utilization of a DNA Hybridization-Based, Rapid Molecular Diagnostic Test for Faster Bacterial Identification and Antimicrobial Optimization in Bacteremic Patients
Outcomes Utilizing Pharmacist Intervention and Rapid Molecular Diagnostic Technology (RMDT) in Patients with Gram-Positive Bloodstream Infections (BSI)
Pages
